This work was supported by grants from the COVID-19 Rapid Research Fund (C-191-2426729-NAZY), the Canadian Institute of Health Research-COVID-19 Immunity Task Force (VR2-173204), the Ontario Research Fund (2426729) (I.N.), and the Academic Health Sciences Organization (HAH-21-02) (D.M.A.).
No takes yet. Share an insight, caveat, or question.
Appelbaum et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: